Temozolomide and its stability—a critical factor

Zenab Attari; C. Mallikarjuna Rao; Lalit Kumar; K. B. Koteshwara

doi:10.1166/asl.2017.8486

Temozolomide and its stability—a critical factor

Zenab Attari, C. Mallikarjuna Rao, Lalit Kumar, K. B. Koteshwara

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

Temozolomide is an alkylating agent, used in the treatment of glioblastoma multiforme. The characterization of the pure drug and its expired batch was carried out to evaluate the changes occurred due to degradation of the drug. FT-IR spectrocscopy, DSC analysis and drug content estimation were carried out. The observations indicated the changes in the drug peak and content after expiry period.

Original language	English
Pages (from-to)	1841-1845
Number of pages	5
Journal	Advanced Science Letters
Volume	23
Issue number	3
DOIs	https://doi.org/10.1166/asl.2017.8486
Publication status	Published - 01-03-2017

All Science Journal Classification (ASJC) codes

Health(social science)
Computer Science(all)
Education
Mathematics(all)
Environmental Science(all)
Engineering(all)
Energy(all)

Access to Document

10.1166/asl.2017.8486

Cite this

@article{cd45130e3a75426ea2d0ec54f9277f3b,

title = "Temozolomide and its stability—a critical factor",

abstract = "Temozolomide is an alkylating agent, used in the treatment of glioblastoma multiforme. The characterization of the pure drug and its expired batch was carried out to evaluate the changes occurred due to degradation of the drug. FT-IR spectrocscopy, DSC analysis and drug content estimation were carried out. The observations indicated the changes in the drug peak and content after expiry period.",

author = "Zenab Attari and Rao, {C. Mallikarjuna} and Lalit Kumar and Koteshwara, {K. B.}",

year = "2017",

month = mar,

day = "1",

doi = "10.1166/asl.2017.8486",

language = "English",

volume = "23",

pages = "1841--1845",

journal = "Advanced Science Letters",

issn = "1936-6612",

publisher = "American Scientific Publishers",

number = "3",

}

TY - JOUR

T1 - Temozolomide and its stability—a critical factor

AU - Attari, Zenab

AU - Rao, C. Mallikarjuna

AU - Kumar, Lalit

AU - Koteshwara, K. B.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Temozolomide is an alkylating agent, used in the treatment of glioblastoma multiforme. The characterization of the pure drug and its expired batch was carried out to evaluate the changes occurred due to degradation of the drug. FT-IR spectrocscopy, DSC analysis and drug content estimation were carried out. The observations indicated the changes in the drug peak and content after expiry period.

AB - Temozolomide is an alkylating agent, used in the treatment of glioblastoma multiforme. The characterization of the pure drug and its expired batch was carried out to evaluate the changes occurred due to degradation of the drug. FT-IR spectrocscopy, DSC analysis and drug content estimation were carried out. The observations indicated the changes in the drug peak and content after expiry period.

UR - http://www.scopus.com/inward/record.url?scp=85017678425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017678425&partnerID=8YFLogxK

U2 - 10.1166/asl.2017.8486

DO - 10.1166/asl.2017.8486

M3 - Article

AN - SCOPUS:85017678425

SN - 1936-6612

VL - 23

SP - 1841

EP - 1845

JO - Advanced Science Letters

JF - Advanced Science Letters

IS - 3

ER -

Temozolomide and its stability—a critical factor

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this